Erwinase® (asparaginase Erwinia chrysanthemi) (Revised)

Billing team must immediately access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a58485a to identify specific changes from the prior version. Once reviewed: (1) Update billing system to reflect any new or modified prior authorization requirements for Erwinase claims; (2) Notify oncology providers of updated authorization procedures; (3) Identify any changes to medical necessity documentation requirements; (4) Train staff on revised submission process. Without this action, claims for Erwinase may be denied or delayed. NOTE: This analysis is limited by access to summary only—full policy content must be reviewed to identify specific billing codes, effective date, and detailed requirements.